Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Hayward Medical Communications adds to its team

Paul Thomas and Alice Pinion among the UK agency's new recruits

- PMLiVE

Regeneron bags US approval for eczema drug Dupixent

Aims to balance affordability and rewarding innovation with the treatment's pricing

- PMLiVE

Channel strategy and channeling your inner disrupter

Is this the answer to many of today's marketing challenges?

- PMLiVE

MMRI strengthens leadership team with new commercial director

Colin Williams joins the firm from PharmiWeb Solutions

- PMLiVE

Pfizer resurrects its OTC bid for Viagra in the UK

Confirms MHRA review of new pharmacist-supplied status has begun

ABPI London offices

Nearly half of HCPs refuse to disclose pharma payments

Industry data shows firms spent £363m on working with healthcare professionals

National Institute for Health and Care Excellence NICE logo

NICE knocks-back Shire’s pancreatic cancer drug Onivyde

Final guidance rules it's not a cost-effective use of NHS resources

EMA establishes big data taskforce

Will explore how research and medicines development can be supported

- PMLiVE

Tesaro joins PARP parade with US approval of Zejula

Unlike its rivals Zejula doesn’t require a BRCA mutation in patients before use

- PMLiVE

Dr Thomas Lynch Jnr takes up new role at Bristol-Myers Squibb

Will focus on leading the firm's research and development programme

- PMLiVE

Keytruda and Opdivo backed for new uses in Europe

CHMP recommendations also include Trumenba, Dinutuximab beta and Refixia

- PMLiVE

Therachon appoints new chief medical officer

Dr Maarten Kraan joins the company from AstraZeneca

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links